The improved lung deposition of hydrofluoroalkane-134a beclomethasone dipropionate ( HFA-BDP ) extrafine aerosol compared with chlorofluorocarbon beclomethasone dipropionate ( CFC-BDP ) suggests that lower doses of HFA-BDP may be required to provide equivalent asthma control .
